J. Juárez

Hospital General de México — Mexico

Medicine · Health Sciences

11h-index628citations19works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cell Adhesion Molecules Research(3), Glycosylation and Glycoproteins Research(2), Protease and Inhibitor Mechanisms(2), Parvovirus B19 Infection Studies(2), Cancer Immunotherapy and Biomarkers(1)

Publications18 total

Low Grade Pulmonary Spindle Cell Neoplasm in a 30‐Year‐Old Asymptomatic Female: A Diagnostic Dilemma: A Case Report
Respirology Case Reports·2025Open Access
29 - Prediction of Improvement in Defecatory Dyssynergia: Anal Sensitivity Assessed by Endocavitary Surface Electrostimulation as a Prognostic Tool.
Continence·2025Open Access
Longitudinal T-Cell Receptor Analysis of Patients with Locally Advanced NSCLC Treated with Hypofractionated Chemoradiation and SABR Boost
International Journal of Radiation Oncology*Biology*Physics·2024
Synthesis, molecular modelling, in vitro biological profiling, and in vivo efficacy studies of a novel family of huprine-based multi-target anti-alzheimer compounds.
Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna)·2013
Identification of biomarkers for the antiangiogenic and antitumour activity of the superoxide dismutase 1 (SOD1) inhibitor tetrathiomolybdate (ATN-224)
British Journal of Cancer·2008· 76 citedOpen Access
Early Biomarkers for the Anti-Angiogenic and Anti-Tumor Activity of the Superoxide Dismutase 1 (SOD1) Inhibitor Tetrathiomolybdate.
Blood·2007
411 POSTER SOD1 inhibition by tetrathiomolybdate demonstrates differential sensitivity against melanoma cell lines in vitro and in vivo: a possible method for identifying patients most likely to benefit from the second generation tetrathiomolybdate, ATN-224
European Journal of Cancer Supplements·2006
132 POSTER Translation of in vitro markers of the anti-angiogenic and anti-tumor activity of the SOD1 inhibitor ATN-224 to clinical trials
European Journal of Cancer Supplements·2006· 1 cited
Immunohistochemical characterisation of the monoclonal antibody BLCA-38 for the detection of prostate cancer
Cancer Immunology Immunotherapy·2004· 22 citedOpen Access
Design of novel N-(2,4-dioxo-1,2,3,4-tetrahydro-thieno[3,2-d]pyrimidin-7-yl)-guanidines as thymidine phosphorylase inhibitors, and flexible docking to a homology model
Bioorganic & Medicinal Chemistry Letters·2003· 24 citedOpen Access
Stimulation of urokinase-type plasminogen activator receptor expression by PMA requires JNK1-dependent and -independent signaling modules
Oncogene·1998· 46 cited
Regulation of 92 kDa type IV collagenase expression by the jun aminoterminal kinase- and the extracellular signal-regulated kinase-dependent signaling cascades
Oncogene·1997· 235 cited
Effect of PD 098059, a specific inhibitor of mitogen-activated protein kinase kinase, on urokinase expression and in vitro invasion.
PubMed·1996· 54 cited
Efficacy of high‐temperature dry heat in inactivating parvovirus
Haemophilia·1996· 2 cited
Up-regulation of urokinase-type plasminogen activator expression by the HER2/neu proto-oncogene.
PubMed·1995· 24 cited
Seroprevalence of parvovirus B19, cytomegalovirus, hepatitis A virus and hepatitis E virus antibodies in haemophiliacs treated exclusively with clotting‐factor concentrates considered safe against human immunodeficiency and hepatitis C viruses
Haemophilia·1995· 18 cited
Induction of M(r) 92,000 type IV collagenase expression in a squamous cell carcinoma cell line by fibroblasts.
PubMed·1995· 78 cited
Abstracts of posters
Pharmacy World & Science·1994· 24 cited

Frequent Co-authors

Fernando Doñate(5), Andrew P. Mazar(5), Rebecca J. Gum(4), Ernst Lengyel(3), Douglas D. Boyd(3), Mark E. Burnett(3), Mari Manuia(3), Olcay Batuman(3), David E. Shaw(2), Eric L. Smith(2), Ahmet Can Timuçin(2), Marc Braunstein(2), M. Moltempi(2), A Rossignoli(2), José Bruno Montoro Ronsano(2), J Tusell(2), Carmen Altisent(2), H Wang(1), Gary L. Clayman(1), Motoharu Seiki(1)